Lamotrigine Tablet
Product Images NDC 13668-049

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 13668-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 01

Chemical structure of lamotrigine, a prescription drug active ingredient. The structure shows a chlorinated aromatic ring and a triazine ring with amino groups attached.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 02

A line graph showing failure probability (%) on the vertical axis versus weeks on the horizontal axis. Two curves are plotted, labeled Placebo and Lamotrigine, with a notation for censored data points. The graph depicts comparative failure probability trends over approximately 100 weeks for Lamotrigine and Placebo groups.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 03

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over a period of approximately 80 weeks. The vertical axis shows failure probability in percentage, and the horizontal axis shows time in weeks. The curves indicate failure probability trends for both Lamotrigine and placebo treatment groups, with censored data points marked along the lines.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 04

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 07

Lamotrigine Tablets, USP 25 mg tablet label from Torrent Pharmaceuticals Limited. The label states each tablet contains 25 mg lamotrigine and includes storage instructions, dosage advisory, and manufacturer information. The NDC number 13668-045-30 and barcode are also visible.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 08

Lamotrigine Tablets USP 25 mg label for a 30-tablet container from Torrent Pharmaceuticals Limited. The label includes storage instructions, dosage form as oral tablets, and states the product is prescription-only (Rx only). The label also shows the NDC 13668-045-30 and manufacturing information for Torrent Pharmaceuticals Ltd., India, and Torrents Pharma Inc., Levittown, PA.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 09

Lamotrigine Tablets, USP 100 mg oral tablet package label by Torrent Pharmaceuticals Limited. The label indicates a 30-tablet supply, storage instructions between 20 to 25°C with permitted excursions, and a child-resistant container. It includes caution to verify the product dispensed and dispensing medication guide instructions. The label shows the NDC number and manufacturer details.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 10

Lamotrigine Tablets, USP 100 mg oral tablets in a 30-tablet package. The label indicates storage conditions and usual dosage note, with the product manufactured by Torrent Pharmaceuticals Limited. The label includes the NDC number 13668-047-30 and a barcode for scanning.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 11

Lamotrigine Tablets, USP 150 mg oral tablet label by Torrent Pharmaceuticals Limited. The label indicates a package of 30 tablets, with storage instructions and a caution to verify product dispensed. It includes manufacturer information and an NDC number 13668-048-30. The label is designed for prescription use only.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 12

Lamotrigine Tablets, USP 150 mg label for 30 tablets in a bottle. The label shows storage instructions, dosage reference, manufacturer details as Torrent Pharmaceuticals Limited, and features a barcode and NDC 13668-048-30. It states the product is Rx only.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 13

Label for Lamotrigine Tablets, USP 200 mg by Torrent Pharmaceuticals Limited. The oral tablet packaging contains 30 tablets. The label includes storage instructions, dosage warnings, and dispensing cautions, along with manufacturer details for Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. The NDC number is 13668-049-30.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 14

Lamotrigine Tablets, USP 200 mg tablet label from Torrent Pharmaceuticals Limited. The label indicates a bottle of 30 tablets with NDC 13668-049-30, including storage instructions, dosage information, and manufacturer details for Torrent Pharmaceuticals Ltd., India. The packaging includes barcode and child-resistant container warning.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 15

Lamotrigine Tablets, USP Starter Kit 25 mg oral tablets packaging label contains 35 tablets (5x7 unit dose) indicated for patients taking valproate. The label shows dosage instructions for weeks 1 to 5, storage conditions, and cautionary statements. Manufactured by Torrent Pharmaceuticals Limited.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 16

Packaging label of Lamotrigine Tablets, USP Starter Kit by Torrent Pharmaceuticals Limited. The label indicates tablets with strengths of 25 mg and 100 mg. The label includes usage caution for patients not taking certain medications and dosage instructions in a small table. The packaging is primarily white and orange with Rx only and barcode visible.*

FDA Label Image

708290c4 B959 47cc 95a1 38a6270297e5 1119 2

An illustration showing the dimensional drawings of Lamotrigine tablets in four strengths: 25 mg, 100 mg, 150 mg, and 200 mg. Each strength is depicted with an upper face showing specific embossed numbers and a lower face featuring a scored line or plain surface for identification.*

FDA Label Image

708290c4 B959 47cc 95a1 38a6270297e5 1119 3

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.